Literature DB >> 22333288

Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus.

June Liu1, Peter J Kerr, John D Wright, Tanja Strive.   

Abstract

Serological cross reactivity between the virulent rabbit haemorrhagic disease virus (RHDV) and the closely related but non-pathogenic rabbit calicivirus (RCV) makes it difficult to study the epidemiology of each virus and the interaction between them when both viruses co-circulate in wild rabbit populations. ELISA methods for the diagnosis of RHDV infection are well characterized, but no specific serological tests for RCV have been developed. Following the characterization of Australian non-pathogenic RCV-A1 strains, we used virus-like-particles (VLPs) and anti-RCV-A1 specific antibodies to establish a set of isotype ELISAs for detection of IgG, IgA and IgM in rabbit sera and secretory mucosal IgA in rectal swabs, and two competition ELISAs. These assays were used to discriminate between anti-RCV-A1 and anti-RHDV antibodies in rabbits. The isotype ELISAs were highly sensitive for detection of anti-RCV-A1 antibodies, but varying levels of cross reactivity from anti-RHDV antibodies occurred in the isotype ELISAs and one competition ELISA. However, the second competition ELISA specifically detected antibodies to RCV-A1 and showed no cross reactivity to anti-RHDV sera. These ELISAs provide important tools to monitor RCV-A1 infection when it occurs alone, and to discriminate between RHDV and RCV-A1 infection when they occur in the same rabbit population. When used in parallel with RHDV serology, they could be used to monitor the dynamics of these two closely related but pathogenically distinct viruses in wild and domestic rabbit populations.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333288     DOI: 10.1016/j.vetmic.2012.01.018

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

1.  Host-Specific Glycans Are Correlated with Susceptibility to Infection by Lagoviruses, but Not with Their Virulence.

Authors:  Ana M Lopes; Adrien Breiman; Mónica Lora; Béatrice Le Moullac-Vaidye; Oxana Galanina; Kristina Nyström; Stephane Marchandeau; Ghislaine Le Gall-Reculé; Tanja Strive; Aleksija Neimanis; Nicolai V Bovin; Nathalie Ruvoën-Clouet; Pedro J Esteves; Joana Abrantes; Jacques Le Pendu
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Benign Rabbit Calicivirus in New Zealand.

Authors:  Leila J Nicholson; Jackie E Mahar; Tanja Strive; Tao Zheng; Edward C Holmes; Vernon K Ward; Janine A Duckworth
Journal:  Appl Environ Microbiol       Date:  2017-05-17       Impact factor: 4.792

3.  The non-pathogenic Australian rabbit calicivirus RCV-A1 provides temporal and partial cross protection to lethal Rabbit Haemorrhagic Disease Virus infection which is not dependent on antibody titres.

Authors:  Tanja Strive; Peter Elsworth; June Liu; John D Wright; John Kovaliski; Lorenzo Capucci
Journal:  Vet Res       Date:  2013-07-08       Impact factor: 3.683

4.  Rabbit haemorrhagic disease: virus persistence and adaptation in Australia.

Authors:  Nina I Schwensow; Brian Cooke; John Kovaliski; Ron Sinclair; David Peacock; Joerns Fickel; Simone Sommer
Journal:  Evol Appl       Date:  2014-08-14       Impact factor: 5.183

5.  An in vivo system for directed experimental evolution of rabbit haemorrhagic disease virus.

Authors:  Robyn N Hall; Lorenzo Capucci; Markus Matthaei; Simona Esposito; Peter J Kerr; Michael Frese; Tanja Strive
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

6.  A sensitive and specific blocking ELISA for the detection of rabbit calicivirus RCV-A1 antibodies.

Authors:  June Liu; Peter J Kerr; Tanja Strive
Journal:  Virol J       Date:  2012-09-03       Impact factor: 4.099

7.  Comparative analysis of rabbit hemorrhagic disease virus (RHDV) and new RHDV2 virus antigenicity, using specific virus-like particles.

Authors:  Juan Bárcena; Beatriz Guerra; Iván Angulo; Julia González; Félix Valcárcel; Carlos P Mata; José R Castón; Esther Blanco; Alí Alejo
Journal:  Vet Res       Date:  2015-09-24       Impact factor: 3.683

8.  Comparative quantitative monitoring of rabbit haemorrhagic disease viruses in rabbit kittens.

Authors:  Markus Matthaei; Peter J Kerr; Andrew J Read; Paul Hick; Stephanie Haboury; John D Wright; Tanja Strive
Journal:  Virol J       Date:  2014-06-09       Impact factor: 4.099

9.  Distribution and prevalence of the Australian non-pathogenic rabbit calicivirus is correlated with rainfall and temperature.

Authors:  June Liu; Damien A Fordham; Brian D Cooke; Tarnya Cox; Greg Mutze; Tanja Strive
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Detection and Circulation of a Novel Rabbit Hemorrhagic Disease Virus in Australia.

Authors:  Jackie E Mahar; Andrew J Read; Xingnian Gu; Nadya Urakova; Roslyn Mourant; Melissa Piper; Stéphanie Haboury; Edward C Holmes; Tanja Strive; Robyn N Hall
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.